SFX by Ex Libris Inc.

Title:	Regulation of stem cell therapies under attack in Europe: for whom the bell tolls
Source:	Embo Journal [0261-4189] Bianco, Paolo yr:2013

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dresser, R. "Stem Cell Research as Innovation : Expanding the Ethical and Policy Conversation." The Journal of Law, Medicine & Ethics 38.2 (2010): 332-341.
description	2.	De Rosa, L. "Cell biology: Dormant and restless skin stem cells." Nature 489.7415 (2012): 215-217.
description	3.	"Intellectual Property: Stem Cells Industry and Beyond: What is the Aftermath of Brüstle?" European journal of risk regulation : EJRR. 1: 93-97.
description	4.	Bubela, T. "Is belief larger than fact: expectations, optimism and reality for translational stem cell research." BMC medicine 10.1 (2012): 133-133.
description	5.	Brevignon-Dodin, L. "ATMP in practice: Towards a new industry landscape in tissue engineering." Journal of Commercial Biotechnology 15.1 (2009): 59-65.
description	6.	Mascre, G. "Distinct contribution of stem and progenitor cells to epidermal maintenance." Nature 489.7415 (2012): 257-262.
description	7.	Doerflinger, Richard M. "Old and New Ethics in the Stem Cell Debate." The Journal of Law, Medicine & Ethics 38.2 (2010): 212-219.
description	8.	Nielsen, Michael E. "Religious Orientation, Personality, and Attitudes About Human Stem Cell Research." The International journal for the psychology of religion 19.2 (2009): 81-91.
description	9.	Glinka, Y. "Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation." Biochemical and biophysical research communications 425.4 (2012): 775-80.
description	10.	Robinson, Hollie C. "How do microRNAs affect vascular smooth muscle cell biology?" Current opinion in lipidology 23.5 (2012): 405-411.
description	11.	White, Yvonne A R A. "Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women." Nature medicine 18.3 (2012): 413-421.
description	12.	Lok, C. "Stem-cell research: Never say die." Nature 481.7380 (2012): 130-3.
description	13.	Centeno, Christopher J. "Is cosmetic platelet-rich plasma a drug to be regulated by the Food and Drug Administration?" Journal of cosmetic dermatology 10.3 (2011): 171-173.
description	14.	Ziegele, B. "The Innovation Office of the Paul-Ehrlich-Institut. Regulatory support during the scientific development of ATMP." Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 54.7 (2011): 857-866.
description	15.	Liras, A. "Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects." Journal of translational medicine 8.194047176 (2010): 131-131.
description	16.	Spence, Julia C. "Uptake and effectiveness of the Children's Fitness Tax Credit in Canada: The rich get richer." BMC public health 10.1 (2010): 356-356.
description	17.	Klostergaard, L. "Embryonic stem cell research is not dehumanising us." Journal of Medical Ethics 35.12 (2009): 774-777.
description	18.	Denker, H. "Induced pluripotent stem cells: how to deal with the developmental potential." Reproductive biomedicine online 19.1 (2009): 34-7.
description	19.	D'Alessandro, Donna M. "Formative evaluation of a pediatric digital library's educational content and comparison to national curricular standards." Medical Teacher 30.9-10 (2008): 880-6.
description	20.	Moller MS, Mark S S. "Human embryonic stem cell research, justice, and the problem of unequal biological access." Philosophy, ethics, and humanities in medicine 3.22 (2008): 22-13.